Literature DB >> 24912448

Two-dimensional spectroscopic imaging with combined free induction decay and long-TE acquisition (FID echo spectroscopic imaging, FIDESI) for the detection of intramyocellular lipids in calf muscle at 7 T.

Ivica Just Kukurova1, Ladislav Valkovič, Wolfgang Bogner, Martin Gajdošík, Martin Krššák, Stephan Gruber, Siegfried Trattnig, Marek Chmelík.   

Abstract

The aim of this study was to introduce a two-dimensional chemical shift imaging (2D CSI) sequence, with simultaneous acquisition of free induction decay (FID) and long TEs, for the detection and quantification of intramyocellular lipids (IMCLs) in the calf at 7 T. The feasibility of the new 2D CSI sequence, which acquires FID (acquisition delay, 1.3 ms) and an echo (long TE) in one measurement, was evaluated in phantoms and volunteers (n = 5): TR/TE*/TE = 800/1.3/156 ms; 48 × 48 matrix; field of view, 200 × 200 × 20 mm(3) ; Hamming filter; no water suppression; measurement time, 22 min 2 s. The IMCL concentration and subcutaneous lipid contamination were assessed. Spectra in the tibialis anterior (TA), gastrocnemius (GM) and soleus (SOL) muscles were analyzed. The water signal from the FID acquisition was used as an internal concentration reference. In the spectra from subcutaneous adipose tissue (SUB) and bone marrow (BM), an unsaturation index (UI) of the vinyl-H (5.3 ppm) to methyl-CH3 ratio, and a polyunsaturation index (pUI) of the diallylic-H (2.77 ppm) to -CH3 ratio, were calculated. Long-TE spectra from muscles showed a simplified spectral pattern with well-separated IMCL for several muscle groups in the same scan. The IMCL to water ratio was largest in SOL (0.66% ± 0.23%), and lower in GM (0.37% ± 0.14%) and TA (0.36% ± 0.12%). UI and pUI for SUB were 0.65 ± 0.06 and 0.18 ± 0.04, respectively, and for BM were 0.60 ± 0.16 and 0.18 ± 0.08, respectively. The new sequence, with the proposed name 'free induction decay echo spectroscopic imaging' (FIDESI), provides information on both specific lipid resonances and water signal from different tissues in the calf, with high spectral and spatial resolution, as well as minimal voxel bleeding and subcutaneous lipid contamination, in clinically acceptable measurement times.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  1H chemical shift imaging (1H CSI); 7 T; calf; free induction decay (FID); intramyocellular lipid (IMCL); long TE

Mesh:

Substances:

Year:  2014        PMID: 24912448     DOI: 10.1002/nbm.3148

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  5 in total

1.  Detection and Alterations of Acetylcarnitine in Human Skeletal Muscles by 1H MRS at 7 T.

Authors:  Radka Klepochová; Ladislav Valkovič; Martin Gajdošík; Thomas Hochwartner; Harald Tschan; Michael Krebs; Siegfried Trattnig; Martin Krššák
Journal:  Invest Radiol       Date:  2017-07       Impact factor: 6.016

Review 2.  Magnetic Resonance Imaging of the Musculoskeletal System at 7T: Morphological Imaging and Beyond.

Authors:  Vladimir Juras; Vladimir Mlynarik; Pavol Szomolanyi; Ladislav Valkovič; Siegfried Trattnig
Journal:  Top Magn Reson Imaging       Date:  2019-06

3.  Muscle-Specific Relation of Acetylcarnitine and Intramyocellular Lipids to Chronic Hyperglycemia: A Pilot 3-T 1H MRS Study.

Authors:  Radka Klepochová; Michael Leutner; Alexandra Kautzky-Willer; Martin Krššák; Magdalena Bastian; Michael Krebs; Michael Weber; Siegfried Trattnig
Journal:  Obesity (Silver Spring)       Date:  2020-08       Impact factor: 5.002

Review 4.  Accelerated MR spectroscopic imaging-a review of current and emerging techniques.

Authors:  Wolfgang Bogner; Ricardo Otazo; Anke Henning
Journal:  NMR Biomed       Date:  2020-05-12       Impact factor: 4.044

Review 5.  Proton magnetic resonance spectroscopy in skeletal muscle: Experts' consensus recommendations.

Authors:  Martin Krššák; Lucas Lindeboom; Vera Schrauwen-Hinderling; Lidia S Szczepaniak; Wim Derave; Jesper Lundbom; Douglas Befroy; Fritz Schick; Jürgen Machann; Roland Kreis; Chris Boesch
Journal:  NMR Biomed       Date:  2020-02-05       Impact factor: 4.044

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.